What is Abacavir-lamivudine (ABC/3TC)?
Category: Prescription Drugs
Most popular types: Epzicom Kivexa
Abacavir and lamivudine are antiretroviral agents. Both of these medicines are nucleoside reverse transcriptase inhibitors (NRTIs). The combination of abacavir and lamivudine is used for the treatment of HIV infections in combination with other antiretroviral agents.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Human immunodeficiency virus (HIV) | 257 | 53 | |
| Increase effect of another treatment | 3 | 4 | |
| Support immune health | 3 | 4 | |
| Fatigue | 2 | 1 | |
| Acquired immune deficiency syndrome (AIDS) | 1 | 0 | |
| Emotional tension | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 3 | |
| Moderate | 5 | |
| Mild | 10 | |
| None | 41 |
Commonly reported side effects and conditions associated with Abacavir-lamivudine (ABC/3TC)
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 5 | |
| Anxious mood | 2 | |
| Diarrhea | 2 | |
| Nausea | 2 | |
| Abdominal cramps | 1 | |
| Abdominal pain | 1 |
Why patients stopped taking Abacavir-lamivudine (ABC/3TC)
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Other | 17 | |
| Doctor's advice | 12 | |
| Side effects too severe | 9 | |
| Course of treatment ended | 2 | |
| Personal research | 2 | |
| Did not seem to work | 1 | |
| Expense | 1 |
Duration
Stopped taking Abacavir-lamivudine (ABC/3TC)
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 4 | |
| 1 - 6 months | 5 | |
| 6 months - 1 year | 5 | |
| 1 - 2 years | 5 | |
| 2 - 5 years | 6 | |
| 5 - 10 years | 5 | |
| 10 years or more | 2 |
What people switch to and from
Patients started taking Abacavir-lamivudine (ABC/3TC) after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Emtricitabine-Tenofovir disoproxil fumarate (Truvada) | 3 | |
| Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) | 1 |
Patients stopped taking Abacavir-lamivudine (ABC/3TC) and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Triumeq | 6 | |
| Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) (Trizivir) | 1 | |
| Dolutegravir (DTG) (Tivicay) | 1 | |
| Emtricitabine (FTC) (Emtriva) | 1 | |
| Raltegravir (RAL) (Isentress) | 1 |
Last updated: